For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

The five-year survival rate for patients diagnosed with lung cancer is approximately 15%. For all patients presenting with lung cancer, about 80% have non-small cell lung cancer (NSCLC). Ingrid Kappers performs research into the effectiveness of (new) treatment methods and the optimisation of existing techniques in people diagnosed with NSCLC.

Event details of Surgery after neoadjuvant treatment for non-small cell lung cancer
Date 2 October 2013
Time 14:00 -15:00
Location Agnietenkapel

I. Kappers, Surgery after Neoadjuvant Treatment for Non-Small Cell Lung Cancer: Decision Making and Patient Outcome

Supervisor

Prof. P. Baas

Co-supervisor

Dr H.M. Klomp (NKI-AvL)

Agnietenkapel

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam

Entrance

Free of charge